PNHRSPNHRSPNHRS

  • 2023 COMMITTEES
  • NUHRA
  • REGIONS
  • OPPORTUNITIES
  • News
  • About PNHRS
    • Organizational Chart
    • PNHRS
    • Objectives
    • Vision I Mission I Core Values
    • Strategy Map
    • History
    • Implementing agencies
    • Downloads
    • Gallery
    • TWC Update
    • About PNHRS Law
Christine Jane Gonzalez
Latest News
22 June 2021
Hits: 2378

VCO supports faster recovery from COVID-19 according to PCHRD-funded study

  • Print
  • Email

Virgin coconut oil supports faster recovery from signs and symptoms of COVID-19, based on a study funded by the Department of Science and Technology- Philippine Council for Health Research and Development (DOST-PCHRD).

The project entitled “The Beneficial Effects of Virgin Coconut Oil among Suspect and Probable Cases of COVID-19,” led by Dr. Imelda Angeles-Agdeppa of the DOST- Food and Nutrition Research Institute (DOST-FNRI), conducted a community trial in Sta. Rosa City that evaluated the effects of VCO as an adjunct supplement for COVID-19 by mixing VCO into the cooked meals of suspect and probable COVID-19 cases. In previous studies, VCO has been proven to contain compounds with anti-viral properties. 

According to the National Institutes of Health, an adjunct supplement is a secondary treatment used to support or assist the primary treatment given to a patient. 

The community trial was completed last October 2020 and showed that individuals who received the VCO added in their meals experienced faster recovery from the signs and symptoms of COVID-19. These results suggest that there is a high possibility to use VCO as an adjunct supplement for suspect and probable COVID-19 cases due to its anti-viral properties. 

“These results are proof of our significant progress on the quest to look for accessible, safe, and effective interventions that support COVID-19 recovery. Through these efforts, the DOST-PCHRD hopes to lessen the health burdens of COVID-19 among Filipinos,” said DOST-PCHRD Executive Director Jaime Montoya. 

While interim results provide favorable evidence, researchers emphasize that additional confirmatory studies should be done to determine the effectiveness of VCO as an adjunct supplement for COVID-19. Currently, the Valenzuela trials are still ongoing with 17 graduated participants and 12 ongoing participants. The project team is also coordinating with Muntinlupa City as an additional study site that will include participants with mild to moderate symptoms of COVID-19 which were not covered in the first two study sites. 

Christine Jane Gonzalez
Latest News
31 May 2021
Hits: 2521

DOST, DOH to probe vaccine mixed-dose approach

  • Print
  • Email

The Department of Science and Technology (DOST) and the Department of Health (DOH) will support a research which will look into the possibility of mixing and matching different COVID-19 vaccine brands and platforms through a study involving 3,000 Filipino participants starting June 2021.

“Ideally, an individual should complete two doses of vaccine using the same vaccine product. However, we cannot ignore the existing shortage in the global vaccine supply, which may interfere with the vaccine distribution and administration in the Philippines. It is urgently needed to ascertain the interchangeability of COVID-19 vaccines, as administering the second dose of vaccines with a two-dose regimen is vital in inducing the needed level of protection against the virus,” said DOST Secretary Fortunato de la Peña.

Aiming to determine the safety and analyze the immune response of individuals whose first dose is followed by a second dose of a different vaccine platform, the mixed-dose study will offer clinical data that will provide basis for the DOH in developing guidelines on the vaccination rollout, and on which vaccine regimen may be applied for an Emergency Use Authorization (EUA) during situations of limited vaccine supply.

Pending approval from the Food and Drug Administration (FDA) and health research ethics board, the study expects to enroll participants aged 18 years or older situated in eight priority areas for vaccine rollout following DOH allocation and the COVAX facility guidelines.

Secretary de la Peña further emphasized that the mixed-dose approach, if proven safe and effective, will help address possible shortage of vaccine products as interchangeable use of vaccine brands or platforms will offer flexibility in the vaccination rollout.

While there are similar studies being conducted in other countries, this study will specifically make use of vaccines being used in the country’s COVID-19 vaccination program and generate data from the Filipino people mixing COVID-19 vaccines after the first Sinovac vaccine dose which uses the inactivated virus platform. To be implemented by the Philippine Society for Allergy, Asthma and Immunology (PSAAI), with Dr. Michelle De Vera as the lead, the study will run for 18 months in conjunction with the vaccination rollout using the available vaccine supply in the Philippines.#

Christine Jane Gonzalez
Latest News
15 April 2021
Hits: 2378

DOST-PCHRD, DOH organize Good Clinical Practice (GCP) training program in preparation for vaccine clinical trials

  • Print
  • Email
The Department of Science and Technology - Philippine Council for Health Research and Development (DOST-PCHRD) together with the Department of Health (DOH) organized an online Good Clinical Practice (GCP) training program in preparation for the conduct of vaccine clinical trials.

The GCP training aims to capacitate community healthcare workers (CHWs) on upholding and safeguarding the rights of participants in vaccine clinical trials, and to provide a platform where the CHWs may raise their questions and concerns on the upcoming trial.

Covering different areas that will help ensure the trial’s adherence to scientific and ethical standards, the training will feature modules from notable experts in the field:

1. DOST-PCHRD Executive Director Dr. Jaime C. Montoya - Clinical Trials Administrative Oversight
2. Forum for Ethical Review Committees in Asia and the Western Pacific - Asian Regional Coordinator Dr. Cristina E. Torres - The Dos and Don'ts of Clinical Trials
3. University of the Philippines-Manila Research Ethics Board Coordinator Ms. Edlyn Jimenez - Informed Consent at Recruitment ng Participants
4. Philippine Clinical Research Professionals President Mr. Al Ryan Baniqued - Safety Reporting at Documentation ng Clinical Trials

The training will follow a “flipped classroom” format, where the participants may access the modules at their own time and pace. Certificates will be provided for those who will complete the program.

“Capacitating our community healthcare workers is very critical to ensure the success of vaccine clinical trials, especially since they will serve as the primary touchpoints of the participants," DOST-PCHRD Executive Director Jaime C. Montoya says. "It is our hope that through this program, we will be able to strengthen our efforts by making sure that we will always adhere to the highest scientific and ethical standards,” he adds.
Christine Jane Gonzalez
Latest News
22 April 2021
Hits: 2312

2021 Call for Nominations for Best Mentor in Health Research Award

  • Print
  • Email

The Department of Science and Technology-Philippine Council for Health Research and Development (DOST-PCHRD) recognizes the vital role of the research mentor who selflessly shares knowledge and skills, instills values and attitudes, and inspires those involved in the research process, thereby creating an enabling environment and contributing to capacity-building in research. 

The Best Mentor Award is offered biennially to recognize and reward mentors in health research who have built the capacities of researchers in the health sector and, in the process, propelled significant advances in the Philippine National Health Research System’s (PNHRS) thrusts as identified in the National Unified Health Research Agenda (NUHRA).

Awardees will be selected per cluster (Luzon, Visayas, Mindanao and NCR) and categorized according to their mentees (Undergraduate Students, Graduate Students and Junior/Early Career Researchers). Also, national winners will be chosen for each category who will be awarded during the PNHRS Week Celebration.

OBJECTIVE

Best Mentor Award recognizes excellence in mentorship that results in productivity of mentees in health research.

ELIGIBILITY

A. Who can nominate

The nominating party may be any of the following:

  • head of the nominee’s institution or immediate supervisor
  • colleague/s 
  • trainee/s 
  • student/advisee

Self-nomination is not allowed.

B. Who can be nominated

  1. must be a Filipino citizen
  2. must be with appropriate or relevant academic qualifications 
  3. must be actively involved in mentoring researchers/students or colleagues for at least 3 years 
  4. has a good track record as a researcher in terms of any of the following: publication, product development or policy formulation 
  5. professionally involved in health research activities either as a research program/project leader, principal and co-principal investigator, mentor/adviser/trainer, or author/co-author 
  6. actively involved in any health research activities in the last 5 years such as conduct of research training and extension work, paper presentations, fund generation, research promotion and networking, research agenda setting, and capacity-building activities

*Winners are ineligible for subsequent nominations, while non-winners are still eligible for nominations if they submit a new set of documents but not for consecutive calls of nomination

HOW TO NOMINATE

Submit the recommendation form (either personally delivered, by courier, or thru email) for initial screening to the regional consortium secretariat. (Please refer to the attached list of regional consortia and contact information)

For completed DOST-PCHRD and ASTHRDP scholars, submit entries to DOST-PCHRD for screening and endorsement of the PCHRD Scholar’s Society (PSS).

A. For the qualified nominees

The requirements below should be submitted strictly within the deadline 

1. Five (5) hard copies of the following documents:

1.1. Accomplished curriculum vitae of the nominee using the prescribed format for Best Mentor Award  

1.2. A narrative description (1,000-1,500 words) of the nominee’s mentoring activities using the guide questions provided, accompanied by supporting documents, e.g.  photos and other relevant documentation. 

1.3. Description of other achievements attained related to health research for the last 5 years, including supporting documents e.g., photocopy of certificates of recognition/awards/honors received by the nominee, which are relevant to the nominee’s eligibility criteria in Section IV. B Who can be nominated.

2. Cite names of 5 mentees, their achievements in research, and a narrative description of the nominee’s contribution to the success of each mentored research. 

To be submitted in a folder with proper tabbing and table of contents. Supplemental documents and/or verifications may be required as deemed necessary. 

B. Selection Criteria

There will be a review of nominations by the Cluster/National Selection Committee based on the following criteria:

c.2.1.  Research Guidance                   44%

  • Quantitative Indicators – refer to the no. of research mentees guided, advised or mentored by the candidate; also includes the nominee’s years of experience in mentoring. 
  • Qualitative indicators – to be decided by the evaluators; may include extent, quality/result of the research guidance/mentoring done e.g., awards and other forms of recognition received by the mentor and/or other mentees

c.2.2.  Track Record in Research              21%              

  • Publications refer to peer-reviewed journals during the last 5 years: 
                 ○ main author in a Philippine journal or international journal
                 ○ co-author in a Philippine journal or international journal

  • Awards received refer to recognition received for the research completed as:
                 ○ main author/principal investigator in the Philippines or International 
                 ○ 
co-author/member of a research team in the Philippines or International

  • Paper presented refers to the number of times the nominee presented the research work/paper in conference, workshop by recognized organization (either oral or poster)
  • Completed research covers completed unpublished researches over the last 5 years 

c.2.3.   Dedication in promoting research     20%                                                                                 

  • Types of active involvement in five years
                   ○ Teacher, adviser, panel member, critic
                   ○ 
Advocate of health-related policies
                   ○ 
Reviewer of refereed journal article/editor/member of editorial board/team 
                   ○ 
Member of professional organization/network
                   ○ 
Trainor in training courses/resource person/lecturer
                   ○ 
Research manager/director, coordinator, evaluator

  • Quality of active involvement within 5 years as:
                   ○ Teacher, adviser, panel member, critic
                   ○ 
Advocate of health-related policies
                   ○ 
Reviewer of refereed journal articles, editor/member of editorial team
                   ○ 
Trainor in training courses/resource person
                   ○ 
Research manager, coordinator, evaluator

c.2.4. Contribution towards a supportive research environment      10%
  • Providing research opportunities as:
                   ○ Organizer/initiator of program, project, policy
                   ○ 
Organizer/initiator/member of team for workshops, conferences
                   ○ 
Organizer/initiator/member of team for training courses
                   ○ 
Director/chair/administrator for research
                   ○ 
Study group leader
                   ○ 
Research team leader

 c.2.5. Other Criteria as agreed by the Evaluators 5%   

This may include awards/recognition received by mentees/advisees/students of the nominee or any agreed criteria; impact of R&D in terms of patenting, commercialization, and/or utilization of research results into policies and actions such as training modules developed, teaching manuals, community modules, contribution to national health development/equity and/or relevance of research results in health care delivery; etc


ANNOUNCEMENT OF WINNERS AND PRIZES

  • All qualified nominees will receive certificates of recognition. 
  • Cluster Winners from Luzon, Visayas, Mindanao and National Capital Region will receive respective cash prizes and plaques of recognition. 

                   Mentors of Undergraduate Students -               P50,000.00
                   
Mentors of Graduate Students -                        P50,000.00
                   
Mentors of Junior/Early Career Researchers -  P100,000.00


  • National Winners for each category will receive respective additional cash prizes and trophies which will be awarded during the PNHRS Week Celebration.
                   Mentors of Undergraduate Students -               P150,000.00
                   Mentors of Graduate Students -                        P150,000.00 
                   Mentors of Junior/Early Career Researchers -  P200,000.00


TIMETABLE


Activity


2021 Timeline

Call for nomination

March – 1st week of May

Submission of recommendation form to the consortium

May 14, 2021

Submission of the endorsed recommendation forms to DOST-PCHRD

May 21, 2021

Submission of complete nominee’s documents to DOST-PCHRD

May – June 2021

Pre-screening of nominee’s complete documents

June

Selection Process

     -  Cluster

     -  National

June- July

Awarding of Winners

PNHRS Week

Celebration

(second week of August)

Christine Jane Gonzalez
Latest News
08 April 2021
Hits: 2113

Call for Applications: 2021 DOST-PCHRD Undergraduate Thesis Grant in Natural Products

  • Print
  • Email

The DOST-PCHRD Undergraduate Thesis Grant in Natural Products provides fund support to all undergraduate students who will conduct their thesis on natural products. The program aims to sustain a research culture in natural products to increase the number of research and later on build a pool of researchers/experts specializing in the field. The program supports the Tuklas Lunas (Drug Discovery and Development) program of the Department of Science and Technology-Philippine Council for Health Research and Development (DOST-PCHRD) which aims to develop safe, effective, and affordable alternative drugs from the country’s natural resources.

Thesis grants will be given to two (2) undergraduate entries per region (subject to availability of funds). After completion of the project, a competition will be held for selected qualified students to recognize their innovative work on natural products.

Who can apply?

All undergraduate students of Pharmacy, Chemistry, Nursing, and Health and Allied Sciences who have thesis proposals on natural products may apply. The proposed thesis study must use plants indigenous in the region. The project must be completed a year after receiving the grant.


How to apply?

Applicants should submit the following documents to the Regional Health Research and Development Consortium (RHRDC):

  1. Duly accomplished prescribed research proposal form with college seal
  2. Endorsement letter from the institution signed by the head of the university and the college dean
  3. Soft copy of the proposal (word format)
  4. Hard copy of the proposal using A4 paper (3 copies)
  5. Certificate of plant authentication
  6. Appropriate clearances: 
    • Bureau of Animal Industry clearance for studies involving animal subjects
    • Biosafety Clearance for studies involving genetic engineering and pathogenic organisms
    • National Commission on Indigenous Peoples Clearance for studies involving Indigenous Peoples
    • Gratuitous Permit from Biodiversity Management Bureau for studies involving collection of flora and fauna from DENR Protected Areas
    • Ethical clearance for studies involving human subjects
  7. Curriculum vitae of the students and adviser


Selection Criteria

The research proposals will be rated based on the following criteria:

  1. Technical merit
        • Objectives are specific, measurable, attainable, relevant, and time-bound
        • The study design supports the objectives
        • The study sample and methodology are appropriate
  2.  Data management
        • The plan for data collection is clearly described
        • Quality control procedures for data collection are in place
        • Statistical analysis is well described
  3.  Relevance/Significance
        • The study addresses an important health problem
        • The study contributes to the advancement of scientific knowledge
  4. Proponent/institution’s capacity
        • The investigators are qualified and appropriately trained to carry out the study
        • The proposed study is appropriate to the experience level of the investigators
        • The implementing/cooperating institution is capable of carrying out the proposed study


Thesis Grant 

  • Two (2) thesis proposals will be selected in each region. Researchers will receive a grant amounting to a maximum of Fifty Thousand Pesos (P 50,000.00).
  • The thesis grant will be deposited to the bank account of the thesis adviser and will be liquidated after the completion of the study
  • A Memorandum of Agreement will be signed between the students, adviser, head of the institution, and DOST-PCHRD
  • The grant must be expended as allocated in the approved line-item budget


Cash Award

Six (6) grantees will be selected as finalists to present their studies during the Philippine National Health Research System (PNHRS) week celebration. The top three (3) presentors will receive the following prizes:

First prize = P 30,000.00

P 20,000.00 for the student

 

P 10,000.00 for the adviser

Second prize = P 22,000.00

P 15,000.00 for the student

 

P 7,000.00 for the adviser

Third prize = P 15,000.00

P 10,000.00 for the student

 

P 5,000.00 for the adviser

Consolation prize

P 5,000 per group


Finalists will receive a plaque of recognition.



Schedule of Activities

ACTIVITY

DATE

Call for Applications

March to May 2021

Deadline of submission to the consortium

May 31, 2021

Endorsement of shortlisted entries to DOST-PCHRD

June 11, 2021

Evaluation of thesis proposals by the Selection Committee and Provision of grants to selected grantees

June to July 2021

Conduct of study

August 2021 to May 2022

Submission of completed studies to DOST-PCHRD

June 3, 2022

Selection of oral presentors by the Selection Committee

June to July 2022

Oral Presentation and Announcement of Winners

August 2022



For inquiries, please email 
This email address is being protected from spambots. You need JavaScript enabled to view it..


  1. 5th National R&D Conference to showcase breakthrough technologies in health
  2. UN names PH health research council Director Jaime Montoya as one of 15 scientists to author 2023 Global SDG Report
  3. VCO a potential antiviral agent against COVID-19 — Filipino research
  4. FREQUENTLY ASKED QUESTIONS ON COVID-19 VACCINES

Page 6 of 57

  • Start
  • «
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • »
  • End

fb tw





feedback
PLEASE RATE YOUR EXPERIENCE IN USING THIS WEBSITE

Your rating

no rate selected


email is required

email is invalid

affiliation is required

affiliation is required

PCHRD LOGO small
Republic of the Philippines
Department of Science and Technology
Philippine Council for Health Research and Development
 
Saliksik Building, DOST Compound, Gen. Santos Ave., Bicutan Taguig City, 1631 Philippines
  • NUHRA
  • REGIONS
  • OPPORTUNITIES
  • News
  • About PNHRS
    • Organizational Chart
    • PNHRS
    • Objectives
    • Vision I Mission I Core Values
    • Strategy Map
    • History
    • Implementing agencies
    • Downloads
    • Gallery
    • TWC Update
    • About PNHRS Law